Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib as Neoadjuvant Therapy in Resectable NSCLC
NCT00367679Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of pazopanib in non-small cell lung cancer (NSCLC), sponsored by GSK. Started Nov 2006; status: completed.
02
Drugs
pazopanib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00367679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367679.